Capsaicin for osteoarthritis pain (Q38221267)

31 August 2017

Capsaicin for osteoarthritis pain (English)

1 reference

31 August 2017

Capsaicin for Osteoarthritis Pain (English)

0 references

0 references

2

Graeme Jones

1 reference

31 August 2017

Laura L Laslett

1

1 reference

31 August 2017

Laura L. Laslett

series ordinal

1

0 references

publication date

1 January 2014

1 reference

Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques

31 August 2017

2014

0 references

published in

1 reference

31 August 2017

68

1 reference

31 August 2017

277-291

1 reference

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group

31 August 2017

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0828-6_11

Capsaicin and nociception: from basic mechanisms to novel drugs

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0828-6_11

Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0828-6_11

Stroke risk and NSAIDs: an Australian population-based study

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0828-6_11

The capsaicin receptor: a heat-activated ion channel in the pain pathway

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0828-6_11

Pathogenesis and management of pain in osteoarthritis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0828-6_11

Treatment options in knee osteoarthritis: the patient's perspective

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0828-6_11

Peppers and pain. The promise of capsaicin

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0828-6_11

Pharmacologically induced selective degeneration of chemosensitive primary sensory neurones

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0828-6_11

Pathophysiology of joint pain

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0828-6_11

Responses of single nerve fibres to capsaicin applied to the skin

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0828-6_11

The analgesic efficacy of topical capsaicin is enhanced by glyceryl trinitrate in painful osteoarthritis: a randomized, double blind, placebo controlled study

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0828-6_11

Topical capsaicin in humans: parallel loss of epidermal nerve fibers and pain sensation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0828-6_11

Afferent and spinal mechanisms of joint pain

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0828-6_11

Civamide cream 0.075% in patients with osteoarthritis of the knee: a 12-week randomized controlled clinical trial with a longterm extension

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0828-6_11

Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0828-6_11

Capsaicin-evoked release of substance P from primary sensory neurons

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0828-6_11

The Ile585Val TRPV1 variant is involved in risk of painful knee osteoarthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0828-6_11

Capsaicin-induced ion fluxes in dorsal root ganglion cells in culture

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0828-6_11

Innervation of the human knee joint by substance-P fibers

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0828-6_11

OARSI recommendations for the management of hip and knee osteoarthritis: part III: Changes in evidence following systematic cumulative update of research published through January 2009.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0828-6_11

10.1007/978-3-0348-0828-6_11

31 March 2020

Identifiers

DOI

0 references

1 reference